| Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
|---|
| 01/15/2003 | EP0929509B1 Liquid crystal alkenyl bicyclo 2.2.2]octanes and mixtures and devices containing such compounds |
| 01/14/2003 | US6506936 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 01/14/2003 | US6506909 Method of making trimethylene carbonate |
| 01/14/2003 | US6506517 Surface modified carbonaceous materials |
| 01/09/2003 | WO2003002524A2 Urea derivatives with antiproteolytic activity |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2002062777A9 Amino ceramide-like compounds and therapeutic methods of use |
| 01/09/2003 | US20030006399 Electrooptical display |
| 01/08/2003 | EP1273579A1 Method for purification of cyclic ester |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/07/2003 | US6503949 Glucagon antagonists/inverse agonists |
| 01/07/2003 | US6503463 Applying electromagnetic wave via generator to waste chemicals; selectively heating, decomposing and purging |
| 01/03/2003 | WO2003000646A1 Substituted aromatic ethers as inhibitors of glycine transport |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | CA2451673A1 Substituted aromatic ethers as inhibitors of glycine transport |
| 01/03/2003 | CA2450475A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/02/2003 | US20030004375 Stripping acidulated slurry comprising lactic acid, calcium lactate, and calcium sulfate |
| 01/02/2003 | US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents |
| 01/02/2003 | US20030003396 Reflection, protective or covering layers which can be written on or read by blue, red or infrared light |
| 01/02/2003 | EP1270551A1 Urea derivatives with antiproteolytic activity |
| 01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/02/2003 | EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 01/01/2003 | CN1097602C Compounds with isocyanate group and closed & has reaction activation group to isocyanate group |
| 12/31/2002 | US6500964 By reacting substituted benzaldehyde(s) with alditol(s) such as sorbitol |
| 12/31/2002 | US6500797 Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones |
| 12/31/2002 | US6500503 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices |
| 12/27/2002 | WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 12/26/2002 | US20020198388 Sulfonamides which are aspartyl protease inhibitors; well suited for inhibiting HIV-1 and HIV-2 protease activity |
| 12/26/2002 | US20020198251 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 12/26/2002 | US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 12/26/2002 | US20020198102 Process for treating dioxin-containing exhaust gas and composite catalyst composition for inhibiting generation of dioxin |
| 12/25/2002 | CN1097048C Photo-cross-linkable 1,4-dioxan-2,3-diyl derivs. |
| 12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |
| 12/24/2002 | US6498172 Prostaglandin agonists and their use to treat bone disorders |
| 12/19/2002 | WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/19/2002 | WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 12/19/2002 | WO2002070508A3 Glycolide production process, and glycolic acid composition |
| 12/19/2002 | US20020193447 Chemical intermediates for bronchodilators |
| 12/19/2002 | CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/18/2002 | EP1265887A2 Carbocyclic side chain containing metalloprotease inhibitors |
| 12/18/2002 | EP1265886A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 12/18/2002 | CN1096462C 7,12-dioxabenz [a] anthracene compounds, process for preparing them and pharmaceutical compositions containing them |
| 12/17/2002 | US6495703 The present invention provides a simple and inexpensive process for preparing glycerol carbonate. namely, according to the present invention, glycerol carbonate is prepared by reacting glycerol with urea. |
| 12/12/2002 | WO2002099077A2 Methods and compositions related to tagging of membrane surface proteins |
| 12/12/2002 | WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 12/12/2002 | WO2002098851A1 Derivatives 0f n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, method for producing salts and bases thereof, physiologically active n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, a pharmaceutical composition and curing method |
| 12/12/2002 | WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases |
| 12/12/2002 | WO2002098832A1 Cf2o-bridged, axially substituted cyclohexane derivatives. |
| 12/12/2002 | WO2002098558A1 Catalyst for carboxylic ester production and process for producing carboxylic ester |
| 12/12/2002 | US20020187982 Glucagon antagonists/inverse agonists |
| 12/12/2002 | DE10219542A1 New stable, difluoromethyleneoxy-bridged, axially substituted cyclohexane derivatives, useful in liquid crystalline media for optical or electrooptical displays |
| 12/12/2002 | CA2449813A1 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 12/12/2002 | CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 12/11/2002 | EP1264829A1 Oxygen-containing heterocyclic compounds |
| 12/11/2002 | EP1117636B1 Method for preparing trion-bis(oxime ether) derivatives andrion-mono and trion-bis(oxime ether) derivatives obtained therewith |
| 12/10/2002 | US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 12/10/2002 | US6491983 Omega-hydrofluoroalkyl ethers, precursor carboxylic acids and derivatives thereof, and their preparation and application |
| 12/05/2002 | WO2002096864A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 12/05/2002 | WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 12/05/2002 | WO2002096424A1 Hetereocyclic beta-aminoacids and their use as anti-epileptogenic agents |
| 12/05/2002 | US20020183323 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 12/05/2002 | US20020183321 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 12/05/2002 | DE10125567A1 New N-aroyl-N'-(carbamoyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibiting hypoglycemic agents, especially useful for treating type II diabetes |
| 12/05/2002 | CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 12/05/2002 | CA2448160A1 Heterocyclic beta-amino acids and their use as anti-epileptogenic agents |
| 12/05/2002 | CA2448023A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 12/04/2002 | EP1261679A1 Supertwisted nematic liquid crystal displays, liquid crystal compositions and compounds |
| 12/03/2002 | US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals |
| 12/03/2002 | US6489327 Tryptase inhibitors |
| 11/28/2002 | WO2002072567A3 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 11/28/2002 | WO2002062777A3 Amino ceramide-like compounds and therapeutic methods of use |
| 11/28/2002 | US20020177594 Inhibitors of histone deacetylase |
| 11/27/2002 | CN1382136A N-heterocyclic derivatives as NOS inhibitors |
| 11/27/2002 | CN1381452A 2-ethoxycarbonyl-2-methyl trimethylene carbonate and its preparing process |
| 11/26/2002 | US6486164 Used for treatment of neuropsychological disorders including schizophrenia, mania, dementia, depression, anxiety, compulsive behavior, substance abuse, parkinson-like motor disorders and motion disorders neuroleptic agents. |
| 11/21/2002 | US20020173512 Psychological disorders; antidepressants |
| 11/20/2002 | EP1258491A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 11/19/2002 | US6482860 Pentafluorobenzenesulfonamides and analogs |
| 11/19/2002 | US6482565 Photoresist cross-linker and photoresist composition comprising the same |
| 11/14/2002 | WO2002089782A2 Dioxanes and uses thereof |
| 11/14/2002 | US20020169206 Substituted biphenyl compounds for the treatment of inflammation |
| 11/14/2002 | US20020169157 An aromatic or heteroaromatic amino acid derivative, used for treating disorders related to overexpression of protein tyrosine phosphatase-1B |
| 11/13/2002 | EP1256579A1 Dioxin derivatives and method of measurement therewith |
| 11/13/2002 | CN1379755A Substituted 2-dialkylamino alkylbiphenyl derivatives |
| 11/07/2002 | WO2002087723A1 Reactor for gas/liquid or gas/liquid/solid reactions |
| 11/07/2002 | US20020165203 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 11/07/2002 | DE10120801A1 Reaktor für gas/flüssig oder gas/flüssig/fest-Reaktionen Reactor for gas / liquid or gas / liquid / solid reactions |
| 11/06/2002 | EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 11/06/2002 | EP1064275B1 Process for producing simvastatin and/or its derivatives |
| 11/05/2002 | US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 11/05/2002 | US6476240 Polymers derived from an unsaturated fused cyclic hydrocarbon (such as perhydro-2,3-didehydro-1,4:5,8-dimethanonaphthalene) joined by a linker to an ester group having one or two protected hydroxyls; use as photoresist |
| 10/31/2002 | US20020161265 To ketones and aldehydes, by reacting with alkali hypohalite under alkaline conditions, using selective heterogeneous oxidation catalyst insoluble in the reaction medium that has 4-oxy-2,2,6,6-tetramethylpiperidin-1-oxyl groups |
| 10/31/2002 | US20020161262 Use treating various medical conditions, including pain |
| 10/31/2002 | US20020161206 For inhibiting tumor cell growth |
| 10/31/2002 | US20020157192 4-amino-2-(1-aryloxy-ethyl)phenol compound |
| 10/31/2002 | DE10217771A1 New biscyclohexyl-1,3-dioxan compounds with various terminal substituent groups, used as components of liquid crystal media, e.g. for active matrix displays in monitors, digital cameras and mobile telephones |
| 10/31/2002 | DE10209139A1 Tricyclic compounds useful as components in liquid crystal media are new |
| 10/30/2002 | EP1253148A2 Oxonol dye compound, optical information recording medium using the same, and optical information |
| 10/30/2002 | EP1251822A1 Novel coupler for use in oxidative hair dyeing |
| 10/30/2002 | CN1377335A Process for producing a purified lactic acid solution |